Target intelligence / Profile preview

Cesium ion (Cs+) (Cs+)

Target
Cs+
Molecular classification
Alkali metal ion, Other
01

Overview

Cesium ions (Cs+) are monovalent alkali metal cations that exhibit chemical properties similar to potassium ions (K+). Due to this similarity, cesium is readily absorbed by the human body and distributed into soft tissues, particularly muscle, via potassium transport mechanisms (CDC, 2018). While stable cesium is relatively non-toxic, radioactive isotopes such as Cesium-137 (137Cs) pose severe health risks as they emit beta and gamma radiation, increasing the risk of cancer and acute radiation syndrome (NIH, 2023). In clinical toxicology, cesium ions are the primary target for decorporation therapy using Prussian Blue (ferric hexacyanoferrate), which acts as an ion exchanger in the gut to trap cesium and prevent its enterohepatic recirculation (FDA, 2003). Furthermore, in laboratory settings, cesium is frequently utilized as a pharmacological tool to block potassium channels, thereby facilitating the study of other ionic currents in excitable cells (PubChem, 2024). Effective management of cesium exposure involves monitoring urinary excretion and ensuring the maintenance of electrolyte balance during treatment. This target is unique because the therapeutic intervention focuses on the removal of the ion from the body rather than modulating its biological signaling (StatPearls, 2023).

Other names
Caesium ionCesium-137137CsRadioactive cesium
02

Mechanism of action

Ion exchange and sequestration within the gastrointestinal tract to prevent enterohepatic circulation and promote fecal excretion.

03

Biological functions

Ion transportOther
04

Disease associations

CancerOther
05

Safety considerations

HypokalemiaConstipationGastrointestinal distressRadiation-induced tissue damage
06

Interacting drugs

Prussian Blue

1 more in the full profile.

07

Biomarkers

Urinary cesium concentrationWhole-body countingSerum potassium levels

Beyond the preview

Go deeper on Cesium ion (Cs+) (Cs+).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cesium ion (Cs+) (Cs+).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call